recombinant human prourokinase

recombinant human prourokinase · Tasly Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant human prourokinase, covering 2021-03-18 to 2021-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism [Phase 2]